Health InsurancePharmacy Trump Administration’s PEPFAR Cuts Threaten Global HIV Prevention Drug Rollout Reduced funding jeopardizes access to critical HIV medications worldwide The recent decision by the Trump…Alex CullorApril 7, 2025
340(b)Health CoveragePharmacy Navigating Manufacturer Restrictions: Protecting 340(b) Impact Amid Drug Pricing Pressure The 340(b) Drug Pricing Program is facing unprecedented pressure. A growing number of pharmaceutical manufacturers…Alex CullorMarch 26, 2025